Curium Advances Second Cyclotron Investment Plan in Romania to Expand PET Imaging Access

Curium™ announced it is advancing plans for a second cyclotron investment in Romania, reaffirming the company’s long-term commitment to expan...

July 31, 2026 | Friday | News
Basilea Secures Additional USD 30 Million BARDA Funding for Phase 3 Antifungal Program

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bac...

July 29, 2026 | Wednesday | News
Wellumio Secures $9.75M to Advance Portable Stroke Imaging Technology

Australian medtech investor Bioshore Ventures and US neurotechnology investor Jumpspace Ventures join Wellumio's oversubscribed pre-Series A round in the f...

July 28, 2026 | Tuesday | News
argenx to Acquire Forte Biosciences for $2.2 Billion to Advance Autoimmune Disease Pipeline

Transaction builds on argenx’s prior strategic investment in Forte Biosciences and reflects a disciplined approach to accessing novel biology tha...

July 28, 2026 | Tuesday | News
Lundbeck Receives FDA Fast Track Designation for Narcolepsy Candidate Lu AH69593

Lundbeck announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Lu AH69593, the company's lead oral orexin 2 rece...

July 27, 2026 | Monday | News
Fresenius Launches €200 Million Venture Fund to Invest in Healthcare Innovation

The issuer is solely responsible for the content of this announcement. Fresenius is further expanding its access to innovation networks through its own co...

July 27, 2026 | Monday | News
Synaptiq Therapeutics Launches to Advance SYN-001 for 22q11DS Neuropsychiatric Symptoms

A consortium of European and US-based investors and Nobias Therapeutics announced the launch of Synaptiq Therapeutics, a privately held, clinical-stage bio...

July 27, 2026 | Monday | News
Primrose Bio Secured $2 Million NIH Grant to Advance DNA- and RNA-Based Medicine Research

$2 million grant builds on research to develop sequence elements that improve DNA- and RNA-based medicine efficacy Primrose Bio, Inc., a company with pr...

July 17, 2026 | Friday | News
Sapphiros Secures BARDA-Backed RRPV Agreement to Advance Portable Molecular Diagnostics

Multi-year program supports development of disposable molecular diagnostic platforms for point-of-care, field-use, and emergency response settings  ...

July 16, 2026 | Thursday | News
Warburg Pincus Set to Acquire Pantherx Rare in Deal Valued at Over US$7 Billion

Private equity firm Warburg Pincus is reportedly close to acquiring Pantherx Rare, a leading US specialty pharmacy focused on rare and orphan diseases, in ...

July 13, 2026 | Monday | News
Alberta Cancer Foundation Commits $35 Million to Expand Cancer Clinical Trials Across Alberta

The Alberta Cancer Foundation is investing $35-million to advance cancer clinical trials in Alberta. The amount represents one of the largest investment...

July 08, 2026 | Wednesday | News
Xellar Biosystems Raises $50 Million to Advance AI-Powered 3D Bio Intelligence Platform

Financing will accelerate the development of human-relevant biological data infrastructure, virtual cell technologies, and next-generation drug discovery...

July 01, 2026 | Wednesday | News
Siren Biotechnology Secures $8 Million CIRM Grant to Advance Brain Cancer Gene Therapy

Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer,  announced that the California Institute for Regenerative Medicine (C...

June 29, 2026 | Monday | News
Indiana Unveils ‘BioHeartland Indiana’ to Showcase Its $125 Billion Bioscience Economy

New regional identity unites a more than $100 billion bioscience ecosystem and positions Indiana among the world's leading innovation hubs. BIO Internat...

June 24, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close